Next Article in Journal
A New Survival Score for Patients ≥65 Years Assigned to Radiotherapy of Bone Metastases
Next Article in Special Issue
Machine Learning to Predict the Response to Lenvatinib Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma
Previous Article in Journal
Neoadjuvant Chemotherapy-Chemoradiation for Borderline-Resectable Pancreatic Adenocarcinoma: A UK Tertiary Surgical Oncology Centre Series
Previous Article in Special Issue
Three-Dimensional Quantitative Tumor Response and Survival Analysis of Hepatocellular Carcinoma Patients Who Failed Initial Transarterial Chemoembolization: Repeat or Switch Treatment?
 
 
Review

Article Versions Notes

Cancers 2022, 14(19), 4676; https://doi.org/10.3390/cancers14194676
Action Date Notes Link
article pdf uploaded. 26 September 2022 12:50 CEST Version of Record https://www.mdpi.com/2072-6694/14/19/4676/pdf-vor
article pdf uploaded. 26 September 2022 12:59 CEST Updated version of record https://www.mdpi.com/2072-6694/14/19/4676/pdf-vor
article xml file uploaded 28 September 2022 05:09 CEST Original file -
article xml uploaded. 28 September 2022 05:09 CEST Update https://www.mdpi.com/2072-6694/14/19/4676/xml
article pdf uploaded. 28 September 2022 05:09 CEST Updated version of record https://www.mdpi.com/2072-6694/14/19/4676/pdf
article html file updated 28 September 2022 05:10 CEST Original file -
article html file updated 28 September 2022 10:04 CEST Update -
article html file updated 28 February 2023 15:20 CET Update https://www.mdpi.com/2072-6694/14/19/4676/html
Back to TopTop